These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37190963)

  • 1. Pharmacogenetics of childhood uncontrolled asthma.
    Khare M; Piparia S; Tantisira KG
    Expert Rev Clin Immunol; 2023 May; ():1-14. PubMed ID: 37190963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Medicine in Childhood Asthma: Omic Studies of Treatment Response.
    Perez-Garcia J; Herrera-Luis E; Lorenzo-Diaz F; González M; Sardón O; Villar J; Pino-Yanes M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of pharmacogenomics, epigenomics, and transcriptomics to improve childhood asthma management: Where do we stand?
    Farzan N; Vijverberg SJ; Kabesch M; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2018 Jun; 53(6):836-845. PubMed ID: 29493882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic and pharmacogenomic considerations of asthma treatment.
    Matera MG; Rinaldi B; Calzetta L; Cazzola M
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1159-1167. PubMed ID: 28992739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma pharmacogenetics: responding to the call for a personalized approach.
    Ortega VE; Wechsler ME
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):399-409. PubMed ID: 23799335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma.
    Ferrante G; Fasola S; Malizia V; Licari A; Cilluffo G; Piacentini G; La Grutta S
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine in childhood asthma.
    Slob EM; Maitland-Van der Zee AH; Koppelman GH; Pijnenburg MW
    Curr Opin Allergy Clin Immunol; 2019 Apr; 19(2):141-147. PubMed ID: 30649013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma Pharmacogenomics: 2015 Update.
    Davis JS; Weiss ST; Tantisira KG
    Curr Allergy Asthma Rep; 2015 Jul; 15(7):42. PubMed ID: 26143396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review.
    Farzan N; Vijverberg SJ; Arets HG; Raaijmakers JA; Maitland-van der Zee AH
    Clin Exp Allergy; 2017 Feb; 47(2):271-293. PubMed ID: 27790783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in asthma therapy: where are we and where do we go?
    Park HW; Tantisira KG; Weiss ST
    Annu Rev Pharmacol Toxicol; 2015; 55():129-47. PubMed ID: 25292431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacogenetics of asthma treatment.
    Tantisira K; Weiss S
    Curr Allergy Asthma Rep; 2009 Jan; 9(1):10-7. PubMed ID: 19063819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of treatment with leukotriene modifiers.
    Wechsler ME; Israel E
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):395-401. PubMed ID: 12582322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of asthma.
    Pascual RM; Bleecker ER
    Curr Opin Pharmacol; 2010 Jun; 10(3):226-35. PubMed ID: 20646961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute asthma at the pediatric intensive care unit: can we link the clinical phenotypes to immunological endotypes?
    van den Berg S; Hashimoto S; Golebski K; Vijverberg SJH; Kapitein B
    Expert Rev Respir Med; 2022 Jan; 16(1):25-34. PubMed ID: 34709100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A System Pharmacology Multi-Omics Approach toward Uncontrolled Pediatric Asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJH; Hashimoto S; Brinkman P; Gorenjak M; Toncheva AA; Harner S; Brandstetter S; Wolff C; Perez-Garcia J; Hedman AM; Almqvist C; Corcuera-Elosegui P; Korta-Murua J; Sardón-Prado O; Pino-Yanes M; Potočnik U; Kabesch M; Kraneveld AD; Maitland-van der Zee AH; On Behalf Of The SysPharmPediA Consortium
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34071272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis for personalized medicine in asthma.
    Portelli M; Sayers I
    Expert Rev Respir Med; 2012 Apr; 6(2):223-36. PubMed ID: 22455494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment response heterogeneity in asthma: the role of genetic variation.
    Vijverberg SJH; Farzan N; Slob EMA; Neerincx AH; Maitland-van der Zee AH
    Expert Rev Respir Med; 2018 Jan; 12(1):55-65. PubMed ID: 29115880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood asthma in the new omics era: challenges and perspectives.
    Golebski K; Kabesch M; Melén E; Potočnik U; van Drunen CM; Reinarts S; Maitland-van der Zee AH; Vijverberg SJH;
    Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):155-161. PubMed ID: 31985545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.